These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17989591)

  • 1. Acute axonal poly-radiculoneuropathy associated with partially treated brucellosis: a case report.
    Borhani Haghighi A; Sabayan B
    J Clin Neuromuscul Dis; 2007 Sep; 9(1):262-4. PubMed ID: 17989591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
    Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brucellar polyradiculoneuropathy with axonal involvement].
    Jimenez-Caballero PE; Cabeza CI
    Rev Neurol; 2006 Sep 16-30; 43(6):379-80. PubMed ID: 16981172
    [No Abstract]   [Full Text] [Related]  

  • 4. Brucellosis and polyneuroradiculomyeloencephalitis. A case report.
    Riestra-Castañeda R; González-Garrido A; González-Cornejo S
    Arch Med Res; 1996; 27(3):331-3. PubMed ID: 8854390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brucellosis and acute inflammatory polyradiculoneuropathy].
    García T; Sánchez JC; Maestre JF; Guisado F; Vilches RM; Morales B
    Neurologia; 1989 May; 4(4):145-7. PubMed ID: 2627488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological manifestations indicative of brucellosis].
    Gouider R; Samet S; Triki C; Fredj M; Gargouri A; el Bahri F; Ben Ghorbel I; Kasraoui A; Mhiri C; Mrabet A
    Rev Neurol (Paris); 1999 Mar; 155(3):215-8. PubMed ID: 10339791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
    Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of anti-GM1 antibodies on ionic channel in myelinated nerve].
    Takigawa T; Yasuda H
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1377. PubMed ID: 8752402
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of axonal form of Guillain-Barré syndrome associated with anti-GM1b IgG antibody following Penner 4 Campylobacter jejuni infection].
    Nagayama S; Kurohara K; Matsui M; Kuroda Y; Kusunoki S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):506-8. PubMed ID: 9366179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies.
    Yuki N; Sato S; Inuzuka T; Miyatake T; Yoshino H
    Muscle Nerve; 1992 Jan; 15(1):116. PubMed ID: 1732757
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis.
    Yuki N
    Muscle Nerve; 1994 Jun; 17(6):680-2. PubMed ID: 8196713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute motor axonal neuropathy associated with IgM anti-GM1 following Mycoplasma pneumoniae infection.
    Heckmann JG; Sommer JB; Druschky A; Erbguth FJ; Steck AJ; Neundörfer B
    Eur Neurol; 1999; 41(3):175-6. PubMed ID: 10202255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.